antagonist G,
Arg-Trp-N-methyl-Phe-Trp-Leu-Met-NH2,
arginyl-tryptophyl-N-methylphenylalanyl-tryptophyl-leucyl-methioninamide,
arginyl-tryptophyl-N-methylphenylalanyl-tryptophyl-leucyl-methioninamide, D-Trp,L-Trp,
H-Arg-D-Trp-N(Me)Phe-D-Trp-Leu-Met-NH2,
RW-N(Me)F-WLM-NH2,
Antagonist G,
115150-59-9,
RW-N(Me)F-Wlm-NH2,
Arg-trp-N-methyl-phe-trp-leu-met-NH2,
H-Arg-D-trp-N(Me)phe-D-trp-leu-met-NH2,
Arginyl-tryptophyl-N-methylphenylalanyl-tryptophyl-leucyl-methioninamide,
L-Arginyl-O-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-L-methioninamide,
L-Methioninamide, L-arginyl-O-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-,
an-tagonist g,
C49H66N12O6S,
AC1L4TXI,
AC1Q5IQ7,
(Arg6,D-Trp7.9,N-Me-Phe8)-Substance P (6-11),
MFCD00133831,
AKOS024456877,
ZINC150340663,
n5-(diaminomethylidene)-l-ornithyl-d-tryptophyl-n-methyl-l-phenylalanyl-d-tryptophyl-l-leucyl-l-methioninamide,
LS-172280,
[Arg6,D-Trp7,9,N-MePhe8]-Substance P(6-11),
L-Methioninamide, L-arginyl-D-tryptophyl-N-methyl-L-phenylalanyl-D-tryptophyl-L-leucyl-,
(2S)-2-[[(2R)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-methylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]-4-methylpentanamide,
(S)-N-((5S,8S,11R,14S,17R)-11-((1H-indol-3-yl)methyl)-14-benzyl-5-carbamoyl-18-(1H-indol-3-yl)-8-isobutyl-15-methyl-7,10,13,16-tetraoxo-2-thia-6,9,12,15-tetraazaoctadecan-17-yl)-2-amino-5-guanidinopentanamide,
AR-1K5310,
CID163960,
C49-H66-N12-O6-S,
B5243,
32588-20-8,